Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once Daily Kaletra and Viread in Antiretroviral Naïve Patients
NCT00679926Phase 4Terminated
- Sponsor
- Oklahoma State University Center for Health Sciences
- Start
- May 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir, tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Oklahoma State University Center for Health Sciences. Started May 2008; status: terminated.
02
Drugs
lopinavir + ritonavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00679926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679926.